Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4,414 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.
Schjesvold FH, Dimopoulos MA, Delimpasi S, Robak P, Coriu D, Legiec W, Pour L, Špička I, Masszi T, Doronin V, Minarik J, Salogub G, Alekseeva Y, Lazzaro A, Maisnar V, Mikala G, Rosiñol L, Liberati AM, Symeonidis A, Moody V, Thuresson M, Byrne C, Harmenberg J, Bakker NA, Hájek R, Mateos MV, Richardson PG, Sonneveld P; OCEAN (OP-103) Investigators. Schjesvold FH, et al. Lancet Haematol. 2022 Jan 12:S2352-3026(21)00381-1. doi: 10.1016/S2352-3026(21)00381-1. Online ahead of print. Lancet Haematol. 2022. PMID: 35032434
Development and Validation of a Novel At-home Smell Assessment.
Gupta S, Kallogjeri D, Farrell NF, Lee JJ, Smith HJ, Khan AM, Piccirillo JF. Gupta S, et al. Among authors: lee jj. JAMA Otolaryngol Head Neck Surg. 2022 Jan 13. doi: 10.1001/jamaoto.2021.3994. Online ahead of print. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 35024772
4,414 results